We performed an in silico analysis of prostate cancer patient samples and demonstrated a significant correlation (0.7) between USP12 and USP46 expression (http://cancergenome.nih.gov/) [41] (Figure 2J). This evidence concerns the gene USP46 and prostate carcinoma.